Declaration of interests
S Vuvic and MC Kiernan are directors of companies that hold equity in Clene Nanomedicine. S Vuvic, MC Kiernan, and their respective institutions receive research funding support for the Rescue-ALS study from Clene Nanomedicine. MC Kiernan was Editor-in-Chief of the Journal of Neurology, Neurosurgery and Psychiatry (BMJ Publishers, UK).
Reviewer disclosures
Peer reviewers on this manuscript have no relevant financial or other relationships to disclose.